Clarithromycin description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Clarithromycin

REMEDYREPACK INC.


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

BOXED WARNING



CLARITHROMYCIN DESCRIPTION


Clarithromycin






CLINICAL PHARMACOLOGY


PHARMACOKINETICS





PRECAUTIONSDOSAGE AND ADMINISTRATION






CLINICAL PHARMACOLOGY

MICROBIOLOGY




INDICATIONS AND USAGE

Aerobic Gram-positive Microorganisms




Aerobic Gram-negative Microorganisms




Other Microorganisms



Mycobacteria




INDICATIONS AND USAGE

Helicobacter


Pretreatment Resistance



*
*

Amoxicillin Susceptibility Test Results and Clinical/Bacteriological Outcomes



Aerobic Gram-positive Microorganisms




Aerobic Gram-negative Microorganisms




Anaerobic Gram-positive Microorganisms




Anaerobic Gram-negative Microorganisms


Susceptibility Testing Excluding Mycobacteria and Helicobacter

Dilution Techniques





*
*
*
*






**
Diffusion Techniques





*
*
*
*






**
In vitro Activity of Clarithromycin against Mycobacteria





Susceptibility Testing for Mycobacterium avium Complex (MAC)



Susceptibility Test for Helicobacter pylori


***

**


INDICATIONS & USAGE



Adults








Microbiology

Children




CLINICAL STUDIES: Otitis Media



Prophylaxis



CLARITHROMYCIN CONTRAINDICATIONS


Drug Interactions
CONTRAINDICATIONS

WARNINGS

PRECAUTIONS: Pregnancy



PRECAUTIONS
WARNINGS

PRECAUTIONS

General


DOSAGE AND ADMINISTRATION


PRECAUTIONS

INFORMATION FOR PATIENTS





DRUG INTERACTIONS



CONTRAINDICATIONS








WARNINGS




Antiarrhythmics


Ergotamine/Dihydroergotamine
CONTRAINDICATIONS


Triazolobenziodidiazepines (such as Triazolam and Alprazolam) and Related Benzodiazepines (such as Midazolam)


HMG-CoA Reductase Inhibitors


Sildenafil (Viagra)


CONTRAINDICATIONS


CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY
















PREGNANCY

Teratogenic Effects

Pregnancy Category C

WARNINGS

NURSING MOTHERS



PEDIATRIC USE



GERIATRIC USE

WARNINGSPRECAUTIONS

CLARITHROMYCIN ADVERSE REACTIONS





Post-Marketing Experience






WARNINGSPRECAUTIONS

Changes in Laboratory Values





OVERDOSAGE




DOSAGE & ADMINISTRATION






H. pylori Eradication to Reduce the Risk of Duodenal Ulcer Recurrence

Triple Therapy: Clarithromycin/Lansoprazole/Amoxicillin
INDICATIONS AND USAGECLINICAL STUDIES

Triple Therapy: Clarithromycin/Omeprazole/Amoxicillin
INDICATIONS AND USAGECLINICAL STUDIES

Dual Therapy: Clarithromycin/Omeprazole
INDICATIONS AND USAGECLINICAL STUDIES

Dual Therapy: Clarithromycin/Ranitidine Bismuth Citrate
INDICATIONS AND USAGECLINICAL STUDIES

Children





Mycobacterial Infections

Prophylaxis



Treatment
CLINICAL STUDIES


HOW SUPPLIED















CLINICAL STUDIES

Mycobacterial Infections

Prophylaxis





MAC Bacteremia


Survival

Clarithromycin







Clinically Significant Disseminated MAC Disease


Safety


*
*


Changes in Laboratory Values of Potential Clinical Importance


*
*
Treatment






MAC Bacteremia





Clinically Significant Disseminated MAC Disease





Survival



Safety



*
*

Changes in Laboratory Values



*
*
Otitis Media




*PathogenOutcomeS. pneumoniaeclarithromycin success rate, 13/15 (87%), control 4/5H. influenzae*
Safety





**
Safety


Duodenal Ulcer Associated with H. pylori Infection

Clarithromycin + Lansoprazole and Amoxicillin

H. pylori Eradication for Reducing the Risk of Duodenal Ulcer Recurrence


Triple therapy: Clarithromycin 500 mg b.i.d. + Lansoprazole 30 mg b.i.d. + Amoxicillin 1 gm b.i.d.





**
Clarithromycin + Omeprazole and Amoxicillin Therapy

H. pylori Eradication for Reducing the Risk of Duodenal Ulcer Recurrence



*histology, and/or culture. Patients were included in the analysis if they completed the study. Additionally, if patients dropped out of the study due to an adverse event related to the study drug, they were included in the analysis as failures of therapy. The impact of eradication on ulcer recurrence has not been assessed in patients with a past history of ulcer.**
Safety


ADVERSE REACTIONS


Clarithromycin + Omeprazole Therapy



Duodenal Ulcer Healing



***

Eradication of H. pylori Associated with Duodenal Ulcer



***




**

Safety




**

Changes in Laboratory Values



ADVERSE REACTIONS

Clarithromycin + Ranitidine Bismuth Citrate Therapy







Safety
ADVERSE REACTIONS

ANIMAL PHARMACOLOGY & OR TOXICOLOGY



REFERENCES





PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION














Clarithromycin





Clarithromycin



Clarithromycin

Clarithromycin TABLET

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:49349-332(NDC:0781-1961)
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
CLARITHROMYCIN CLARITHROMYCIN 250 mg

Inactive Ingredients

Ingredient Name Strength
CROSCARMELLOSE SODIUM
HYPROMELLOSES
MAGNESIUM STEARATE
cellulose, microcrystalline
polyethylene glycol
polysorbate 80
povidone
talc
titanium dioxide

Product Characteristics

Color Size Imprint Code Shape
white 15 mm GG;C6 OVAL

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:49349-332-02 30 in 1 BLISTER PACK

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA065144 2011-06-27


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.